| Email Article | Print |
Eye test peers into heat-related multiple sclerosis symptoms
March 24, 2008A bodysuit that heats or cools a patient, combined with painless measurements of eye movements, is providing multiple sclerosis researchers at UT Southwestern Medical Center with a new tool to study the mysterious link between body temperature and severity of MS symptoms.
The researchers studied an aspect of MS called Uhthoff's phenomenon, named for the German ophthalmologist who reported in 1889 that some people have temporary vision problems after exercise or in hot weather. This and other symptoms of MS, such as fatigue or problems with coordination, worsen in the heat for most people with the disease.
Although doctors and researchers have long known about Uhthoff's phenomenon, there has been no way to objectively measure its severity or how it is related to body temperature.
The UT Southwestern study, available online and appearing in the March 25 edition of the journal Neurology, demonstrated that as body temperature rises, the severity of an eye-movement disorder called INO, or internuclear ophthalmoparesis, also increases. When a person with INO looks rapidly from one object to another, one eye moves more slowly than the other. Normally, the eyes move at the same speed.
INO can serve as an easy-to-measure "canary in a coal mine," acting as a surrogate for other heat-related symptoms that are harder to measure, such as fatigue, mental confusion or bladder or bowel problems, said Dr. Elliot Frohman, professor of neurology and ophthalmology, director of the Multiple Sclerosis Program and Multiple Sclerosis Clinical Center at UT Southwestern and senior author of the study.
The researchers' tools were a whole-body suit, riddled with tubes for circulation of water, that can change body temperature; a pill-like thermometer that measures core body temperature after being swallowed; and an infrared camera that painlessly tracks eye movements.
The study, conducted at UT Southwestern, included eight patients with MS who have INO, eight with MS but not INO, and eight healthy control subjects. Warm water in the body garment raised each subject's normal temperature by one-half of a degree Celsius, and the cool water brought it down by one-half of a degree.
The subjects also wore a lightweight device, fitted on a headband, that used infrared light to track their eye movements as they followed a random sequence of blinking lights.
In the subjects with INO, increasing the body temperature worsened the differences between their two eyes' relative motion. Conversely, cooling the body made the eyes synchronize better.
Monitoring INO in a clinical setting could provide a sensitive test to determine a patient's susceptibility to other heat-related MS symptoms, as well as a way to monitor the effectiveness of treatments, Dr. Frohman said.
"With this new technique, we can objectively test new therapies that specifically treat a host of MS-related symptoms," said Dr. Frohman.
The next step in the research, Dr. Frohman said, is to use this system to measure the effectiveness of a drug that appears to relieve heat-induced symptoms in people with MS.
"We've shown that by this method we can model the principal mechanisms that cause certain symptoms to worsen in people with MS," he said.
Other UT Southwestern researchers involved in the study were lead author Dr. Scott Davis, assistant professor of neurology; Teresa Frohman, clinical research manager in neurology; Dr. Craig Crandall, associate professor of internal medicine; Douglas Mills, former research assistant; and Dr. Olaf Stüve, assistant professor of neurology. A researcher from the New Jersey Neuroscience Institute and a nurse from Presbyterian Hospital of Dallas also participated.
The work was supported by the National Multiple Sclerosis Society, Once Upon A Time -, the Cain/Denius Comprehensive Center for Mobility Research, the Sparrow Foundation, and the Hawn Foundation.
Visit http://www.utsouthwestern.org/neurosciences to learn more about
UT Southwestern's clinical services in neurosciences.
The University of Texas Southwestern Medical Center at Dallas
The UT Southwestern study, available online and appearing in the March 25 edition of the journal Neurology, demonstrated that as body temperature rises, the severity of an eye-movement disorder called INO, or internuclear ophthalmoparesis, also increases. When a person with INO looks rapidly from one object to another, one eye moves more slowly than the other. Normally, the eyes move at the same speed.
INO can serve as an easy-to-measure "canary in a coal mine," acting as a surrogate for other heat-related symptoms that are harder to measure, such as fatigue, mental confusion or bladder or bowel problems, said Dr. Elliot Frohman, professor of neurology and ophthalmology, director of the Multiple Sclerosis Program and Multiple Sclerosis Clinical Center at UT Southwestern and senior author of the study.
The researchers' tools were a whole-body suit, riddled with tubes for circulation of water, that can change body temperature; a pill-like thermometer that measures core body temperature after being swallowed; and an infrared camera that painlessly tracks eye movements.
The study, conducted at UT Southwestern, included eight patients with MS who have INO, eight with MS but not INO, and eight healthy control subjects. Warm water in the body garment raised each subject's normal temperature by one-half of a degree Celsius, and the cool water brought it down by one-half of a degree.
The subjects also wore a lightweight device, fitted on a headband, that used infrared light to track their eye movements as they followed a random sequence of blinking lights.
In the subjects with INO, increasing the body temperature worsened the differences between their two eyes' relative motion. Conversely, cooling the body made the eyes synchronize better.
Monitoring INO in a clinical setting could provide a sensitive test to determine a patient's susceptibility to other heat-related MS symptoms, as well as a way to monitor the effectiveness of treatments, Dr. Frohman said.
"With this new technique, we can objectively test new therapies that specifically treat a host of MS-related symptoms," said Dr. Frohman.
The next step in the research, Dr. Frohman said, is to use this system to measure the effectiveness of a drug that appears to relieve heat-induced symptoms in people with MS.
"We've shown that by this method we can model the principal mechanisms that cause certain symptoms to worsen in people with MS," he said.
Other UT Southwestern researchers involved in the study were lead author Dr. Scott Davis, assistant professor of neurology; Teresa Frohman, clinical research manager in neurology; Dr. Craig Crandall, associate professor of internal medicine; Douglas Mills, former research assistant; and Dr. Olaf Stüve, assistant professor of neurology. A researcher from the New Jersey Neuroscience Institute and a nurse from Presbyterian Hospital of Dallas also participated.
The work was supported by the National Multiple Sclerosis Society, Once Upon A Time -, the Cain/Denius Comprehensive Center for Mobility Research, the Sparrow Foundation, and the Hawn Foundation.
Visit http://www.utsouthwestern.org/neurosciences to learn more about
UT Southwestern's clinical services in neurosciences.
The University of Texas Southwestern Medical Center at Dallas
Multiple Sclerosis News and Current Multiple Sclerosis Events RSSNew study shows how genes control blood proteins important to health
A new study shows how genes control levels of many blood proteins implicated in disease. The findings are the result of an international collaboration between scientists at the University of Exeter, the National Institute on Aging, and the Tuscany and Florence Health Agencies.
Inflammation triggers cell fusions that could protect neurons, Stanford research shows
Chronic inflammation triggers bone marrow-derived blood cells to travel to the brain and fuse with a certain type of neuron up to 100 times more frequently than previously believed, according to a new study from the Stanford University School of Medicine.
Vitamin D in brain function
In a definitive critical review, scientists at Children's Hospital & Research Center Oakland ask whether there is convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction.
New data show treatment of multiple sclerosis with AVONEX enhances quality of life
Results from a one-year prospective, observational study conducted to determine the impact of beginning treatment with AVONEX on MS patients' overall quality of life (QoL) were announced today.
Increasing Positive Experiences Decreases Depression Symptoms in Patients with Multiple Sclerosis, MU Professor Finds
Depression is prevalent among people living with chronic diseases, such as multiple sclerosis (MS). Although most people with MS live normal lives, they must manage symptoms and treatments that cause increased emotional and psychological stress on a daily basis. Now, researchers from two universities have found that people with MS who increase positive experiences decrease their symptoms of depression and improve the overall quality of their lives.
Leaky blood vessels open up nerve cells to toxic assault in Lou Gehrig's disease
Leaky blood vessels that lose their ability to protect the spinal cord from toxins may play a role in the development of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, according to research published in the April issue of Nature Neuroscience.
Potential new target for multiple sclerosis therapy
Researchers demonstrate both genetic and pharmaceutical evidence for the role of a protein called collagenase-2 in the development of multiple sclerosis (MS), providing a potential new way to combat this debilitating disease.
Harvard researchers publish MRI images of genes in action in the living brain
Biologists have just confirmed what poets have known for centuries: eyes really are windows of the soul-or at least of the brain.
New stem cell technique improves genetic alteration
UC Irvine researchers have discovered a dramatically improved method for genetically manipulating human embryonic stem cells, making it easier for scientists to study and potentially treat thousands of disorders ranging from Huntington's disease to muscular dystrophy and diabetes.
Study shows effects of vitamin D and skin's physiology
Researchers from Boston University School of Medicine (BUSM) have found that previtamin D3 production varies depending on several factors including skin type and weather conditions.
More Multiple Sclerosis News Articles
| © 2008 BrightSurf.com |